Literature DB >> 27890348

Out-of-the-box pelvic surgery including iliopsoas resection for recurrent gynecological malignancies: Does that make sense? A single-institution case-series.

G Vizzielli1, V Chiantera2, G Tinelli3, A Fagotti4, V Gallotta5, A Di Giorgio6, S Gueli Alletti5, G Scambia4.   

Abstract

OBJECTIVE: To report morbidity and oncological outcomes in a consecutive series of lateral isolated recurrent gynecological cancer involving the pelvic side wall (PSW) including the iliopsoas muscle.
MATERIAL AND METHODS: We retrospectively evaluated a consecutive series between 6/2013 and 12/2015 of lateral isolated recurrent gynecological malignancies treated with a lateral endopelvic resection (LEPR). LEPR was defined as an en-bloc lateral resection of a pelvic tumor with sidewall muscle, and/or bone, and/or major nerve, and/or major vascular structure. Post-surgical complications, quality of life (QoL) and survivals were computed.
RESULTS: Seventy-four women with pelvic isolated relapse were admitted for surgery during the study period. Among them, 8 cases (10.8%) showed lateral isolated relapse involving the iliopsoas muscle and were treated with LEPR. R0 resection was achieved in 6/8 patients (75.0%), while the pathologic margins were microscopically and macroscopically positive in 1 patient (12.5%), respectively. There were no perioperative mortalities. Major postoperative complications occurred in 3 patients (37.5%) through peripheral neuropathies, thrombosis of the vascular graft and compartment syndrome of the leg. Median follow-up time was 21 months (range, 12-28). The 2-year overall survival (OS) was 88% improving up to 100% if R0 resection was achieved. In patients with positive pathologic margins (n = 2), the 2-year OS was 50%. All women showed an improved QoL after surgery.
CONCLUSION: LEPR with iliopsoas resection can be safely performed in selected cases with lateral isolated gynecological relapse involving the PSW and was associated with improved QoL and prolonged survival when an R0 resection was achieved.
Copyright © 2016 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Iliopsoas resection; Lateral endopelvic resection; Pelvic side wall disease; Recurrent gynecological malignancies

Mesh:

Year:  2016        PMID: 27890348     DOI: 10.1016/j.ejso.2016.10.028

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  7 in total

1.  Is a Vaginectomy Enough or is a Pelvic Exenteration Always Required for Surgical Treatment of Recurrent Cervical Cancer? A Propensity-Matched Study.

Authors:  Giuseppe Vizzielli; Lucia Tortorella; Carmine Conte; Vito Chiantera; Valerio Gallotta; Nazario Foschi; Martina Arcieri; Gabriella Ferrandina; Anna Fagotti; Filiberto Zattoni; Giovanni Scambia; Alfredo Ercoli
Journal:  Ann Surg Oncol       Date:  2020-10-15       Impact factor: 5.344

2.  ASO Authors Reflections: Vaginectomy as Surgical Treatment of Recurrent Cervical Cancer.

Authors:  Giuseppe Vizzielli; Vito Chiantera; Alfredo Ercoli; Giovanni Scambia
Journal:  Ann Surg Oncol       Date:  2020-10-24       Impact factor: 5.344

3.  Potential prognostic factors in progression-free survival for patients with cervical cancer.

Authors:  Hui-Hui Chen; Wei-Yu Meng; Run-Ze Li; Qing-Yi Wang; Yu-Wei Wang; Hu-Dan Pan; Pei-Yu Yan; Qi-Biao Wu; Liang Liu; Xiao-Jun Yao; Min Kang; Elaine Lai-Han Leung
Journal:  BMC Cancer       Date:  2021-05-10       Impact factor: 4.430

4.  Impact of surgeon learning curve in minimally invasive radical hysterectomy on early stage cervical cancer patient survival.

Authors:  L Pedone Anchora; N Bizzarri; V Gallotta; V Chiantera; F Fanfani; A Fagotti; F Cosentino; G Vizzielli; V Carbone; G Ferrandina; G Scambia
Journal:  Facts Views Vis Obgyn       Date:  2021-09

5.  Intra and extra pelvic multidisciplinary surgical approach of retroperitoneal sarcoma: Case series report.

Authors:  Heekyoung Song; Jung Hwan Ahn; Yuyeon Jung; Jae Yeon Woo; Jimin Cha; Yang-Guk Chung; Keun Ho Lee
Journal:  World J Clin Cases       Date:  2022-09-26       Impact factor: 1.534

6.  Laterally Extended Endopelvic Resection Versus Chemo or Targeted Therapy Alone for Pelvic Sidewall Recurrence of Cervical Cancer.

Authors:  Soo Jin Park; Jaehee Mun; Seungmee Lee; Yanlin Luo; Hyun Hoon Chung; Jae-Weon Kim; Noh Hyun Park; Yong Sang Song; Hee Seung Kim
Journal:  Front Oncol       Date:  2021-05-25       Impact factor: 6.244

7.  Should the Number of Metastatic Pelvic Lymph Nodes be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer?

Authors:  Luigi Pedone Anchora; Vittoria Carbone; Valerio Gallotta; Francesco Fanfani; Francesco Cosentino; Luigi Carlo Turco; Camilla Fedele; Nicolò Bizzarri; Giovanni Scambia; Gabriella Ferrandina
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.